tiprankstipranks
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Israel Market

Teva (TEVA) Income Statement

Compare
3 Followers

Teva Income Statement

Last quarter (Q3 2024), Teva's total revenue was $4.33B, an increase of 12.49% from the same quarter last year. In Q3, Teva's net income was $-437.00M. See Teva’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 15.85B$ 14.93B$ 15.88B$ 16.66B$ 16.89B
Gross Profit
$ 7.65B$ 6.97B$ 7.59B$ 7.72B$ 7.54B
Operating Expenses
$ 7.21B$ 4.28B$ 4.50B$ 4.67B$ 4.82B
Depreciation and Amortization
$ 1.15B$ 1.31B$ 1.33B$ 1.56B$ 416.00M
EBITDA
$ 1.56B$ -925.00M$ 4.41B$ -1.95B$ 1.28B
Operating Income
$ 433.00M$ -2.10B$ 1.72B$ -3.57B$ -443.00M
Other Income/Expenses
$ -1.05B$ -966.00M$ -1.05B$ -695.00M$ -836.00M
Pretax Income
$ -622.00M$ -3.06B$ 658.00M$ -4.41B$ -1.26B
Net Income
$ -559.00M$ -2.35B$ 417.00M$ -3.99B$ -999.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.50$ -2.12$ 0.38$ -3.64$ -0.92
Diluted EPS
$ -0.50$ -2.12$ 0.38$ -3.64$ -0.92
Weighted Average Shares Outstanding
1.12B 1.11B 1.10B 1.09B 1.09B
Weighted Average Shares Outstanding (Diluted)
1.12B 1.11B 1.11B 1.09B 1.09B
Currency in USD

Teva Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis